» Articles » PMID: 29379273

Quantifying the Treatment Goals of People Recently Diagnosed with Schizophrenia Using Best-worst Scaling

Overview
Date 2018 Jan 31
PMID 29379273
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study seeks to quantify the treatment goals of people recently diagnosed with schizophrenia and explore their impact on treatment plan.

Methods: People aged 18-35 years with a confirmed diagnosis of schizophrenia within the past 5 years were surveyed in the UK, Germany, and Italy. Treatment goals were assessed via a validated best-worst scaling instrument, where participants evaluated subsets of 13 possible treatment goals identified using a balanced incomplete block design. Participants identified the most and least important goals within each task. Data were also collected on current treatment and preference for daily oral versus long-acting injectable (LAI) treatment. Hierarchical Bayes was used to identify preference weights for the goals, and latent class analysis was used to identify segments of people with similar goals. The segments were compared with the current treatment and preference for oral versus LAI treatment.

Results: Across 100 participants, the average age was 26 years, 75% were male and 50% were diagnosed within 2 years ago. Overall, preferences were most favorable for reduced disease symptoms, think clearly, reduced hospitalizations, reduced anxiety, and take care of self. A total of 61% preferred oral medication and 39% LAI. Two groups were identified with different treatment goals; 50% of participants emphasized clinical goals, including reduced disease symptoms (preference weight =19.7%), reduced hospitalizations (15.5%), and reduced anxiety (10.5%). The other 50% emphasized functional goals, including improved relationships with family/friends (11.4%), increased interest in work (10.6%), experiencing a fuller range of emotions (8.4%), and ability to socialize (7.5%). Those emphasizing functional goals were more likely to be on LAI (44% versus 26%; =0.059) and preferred LAI (46% versus 32%; =0.151).

Conclusions: People with recent-onset schizophrenia may focus more on clinical goals or functional goals, a discussion of which may help facilitate patient engagement.

Citing Articles

Lost and found: dynamics of relationship and employment status over time in people with affective and psychotic spectrum disorders.

Senner F, Kerkhoff L, Adorjan K, Lauseker M, Budde M, Heilbronner M BJPsych Open. 2024; 11(1):e11.

PMID: 39721961 PMC: 11733486. DOI: 10.1192/bjo.2024.816.


Reasons for switching oral antipsychotic medications and related patterns of care and costs in patients with schizophrenia initiating monotherapy treatment: Claims-linked chart study.

Fee R, Webb N, Dick L, White J, Essoi B, Walker V J Manag Care Spec Pharm. 2024; 30(7):698-709.

PMID: 38717043 PMC: 11217866. DOI: 10.18553/jmcp.2024.23319.


Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une....

Coronado-Montoya S, Abdel-Baki A, Crockford D, Cote J, Dubreucq S, Dyachenko A Can J Psychiatry. 2024; 69(7):524-535.

PMID: 38571478 PMC: 11168346. DOI: 10.1177/07067437241242395.


Hospitalization and help-seeking among first episode psychosis patients.

Yee A, Greene S, Weiss A, Chaudhry S, Steadman S Discov Ment Health. 2024; 4(1):10.

PMID: 38568391 PMC: 10992493. DOI: 10.1007/s44192-024-00064-7.


Prioritizing Treatment Goals of People Diagnosed with Bipolar I Disorder in the US: Best-Worst Scaling Results.

Bridges J, Goldberg J, Fitzgerald H, Chumki S, Beusterien K, Will O Patient Prefer Adherence. 2023; 17:2545-2555.

PMID: 37849618 PMC: 10578617. DOI: 10.2147/PPA.S419143.


References
1.
Deegan P, Carpenter-Song E, Drake R, Naslund J, Luciano A, Hutchison S . Enhancing Clients' Communication Regarding Goals for Using Psychiatric Medications. Psychiatr Serv. 2017; 68(8):771-775. DOI: 10.1176/appi.ps.201600418. View

2.
Zipursky R, Cunningham C, Stewart B, Rimas H, Cole E, McDermid Vaz S . Characterizing outcome preferences in patients with psychotic disorders: a discrete choice conjoint experiment. Schizophr Res. 2017; 185:107-113. DOI: 10.1016/j.schres.2016.12.018. View

3.
Karson C, Duffy R, Eramo A, Nylander A, Offord S . Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review. Neuropsychiatr Dis Treat. 2016; 12:57-67. PMC: 4708960. DOI: 10.2147/NDT.S96392. View

4.
Beusterien K, Kennelly M, Bridges J, Amos K, Williams M, Vasavada S . Use of best-worst scaling to assess patient perceptions of treatments for refractory overactive bladder. Neurourol Urodyn. 2015; 35(8):1028-1033. DOI: 10.1002/nau.22876. View

5.
Rosenheck R, Stroup S, Keefe R, McEvoy J, Swartz M, Perkins D . Measuring outcome priorities and preferences in people with schizophrenia. Br J Psychiatry. 2005; 187:529-36. DOI: 10.1192/bjp.187.6.529. View